"سبيماكو الدوائية" السعودية.. على طريق تقليص الخسائر

Watch "سبيماكو الدوائية" السعودية.. على طريق تقليص الخسائر - CNBCArabia on Dailymotion

Transcript

00:00 With the support of the growth of revenues and the recovery of spending,

00:04 SPIMACO's results for 2023 show a recovery in losses of more than 98.5%.

00:14 This is the most prominent thing that the company's financial data has shown.

00:18 Starting with the losses in 2022, which were more than 171 million Riyals.

00:26 In 2023, the company had 2.6 million Riyals, which is a recovery of 98.5%.

00:35 Thus, the losses were recorded only at 13% of the total capital.

00:42 As for revenues, which grew by 16.3%.

00:48 In 2022, the company's revenues were 1.4 billion Riyals.

00:54 In 2023, the company had 1.6 billion Riyals.

01:01 In the rest of the company's data, what are the reasons that led to the company's reduction in losses?

01:10 First, we have a recovery in expenses, in addition to the growth of the medical services sector.

01:17 The most prominent thing is the growth of the will to sell drugs at 16%.

01:24 But what about the share of the company in the Saudi market?

01:27 Today, it represents about 17.4% of the total medical and pharmaceutical market in the Kingdom of Saudi Arabia.

01:36 It is distributed in different sectors.

01:38 The private sector has a share of 58% and contributed more than 800 million Riyals.

01:46 The government sector contributed 18.13% and contributed 252 million Riyals.

01:56 The international operations sector contributed 13.14% and contributed 184 million Riyals.

02:05 But what about the latest developments in this company?

02:09 At first, the company announced that it would not distribute profits in 2023.

02:16 In February of the following year, it announced the appointment of a new CEO.

02:23 But perhaps the most prominent thing this year was the company's announcement of signing a number of strategic agreements.

02:31 Especially those related to the import and transfer of the human viral coronavirus.

02:37 So, with the increase in wills and the recovery in expenses,

02:41 Spimak and Saudi Arabia reduce their losses by more than 98%.

02:47 [BLANK_AUDIO]